Anti-cyclic citrullinated peptide antibodies are not associated with familial mediterranean fever

Journal of Back and Musculoskeletal Rehabilitation

Volumn 23, Issue 1, 2010, Pages 21-23

  Karatay, Saliha ^a   Yildirim, Kadir ^a   Erdal, Akin ^a   Uzkeser, Hulya ^a   Erdem, Fazile Hatipoglu ^b   Yanmaz, Vefa ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b State Hospital   (Turkey)

Author keywords

Anti cyclic citrullinated peptide antibodies; Arthritis; Familial Mediterranean fever

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; RHEUMATOID FACTOR;

EID: 77949555132     PISSN: 10538127     EISSN: None     Source Type: Journal    
DOI: 10.3233/BMR-2010-0243     Document Type: Article

References (22)

1. F.C. Arnett, S.M. Edworthy, D.A. Bloch et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum 31 (1988), 315-324.
2. S. Bas, T.V. Perneger, M. Seitz et al., Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors, Rheumatology (Oxford) 41 (2002), 809-814
3. H. Bodur, H. Ucan, S. Seckin et al., Protracted familial Mediterranean fever arthritis, Rheumatol Int 19 (1999), 71-73.
4. L. Bogliolo, C. Alpini, R. Caporali et al., Antibodies to cyclic citrullinated peptides in psoriatic arthritis, J Rheumatol 32 (2005), 511-515.
5. R. Brik, M. Shinawi, L. Kasinetz et al., The musculoskeletal manifestations of familial Mediterranean fever in children genetically diagnosed with the disease, Arthritis Rheum 44 (2001), 1416-1419.
6. M.T. Chan, P. Owen, J. Dunphy et al., Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus, J Rheumatol 35 (2008), 77-83.
7. G. Damían-Abrego, J. Cabiedes and A. Cabral, Anticitrullinated peptide antibodies in lupus patients with or without deforming arthropathy, Lupus 17 (2008), 300-304.
8. V. Ertekin, M.A. Selimoglu and I. Pirim, Familial Mediterranean fever in a childhood population in eastern Turkey, Pediatr Int 47 (2005), 640-644.
9. E. Korendowych, P. Owen, J. Ravindran et al., The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis, Rheumatology (Oxford) 44 (2005), 1056-1060.
10. D.M. Lee and P.H. Schur, Clinical utility of the anti-CCP assay in patients with rheumatic diseases, Ann Rheum Dis 62 (2003), 870-874.
11. A. Livneh, P. Langevitz, D. Zemer et al., Criteria for the diagnosis of familial Mediterranean fever, Arthritis Rheum 40 (1997), 1879-1885
12. J.B. Martinez, J.S. Valero, A.J. Bautista et al., Erosive arthropathy: clinical variance in lupus erythematosus and association with anti-CCP case series and review of the literature, Clin Exp Rheumatol 25 (2007), 47-53.
13. O. Meyer, C. Labarre, M. Dougados et al., Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage, Ann Rheum Dis 62 (2003), 120-126.
14. A. Raptopoulou, P. Sidiropoulos, M. Katsouraki et al., Anticitrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts, Crit Rev Clin Lab Sci 44 (2007), 339-363.
15. J. Samuels and S. Ozen, Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever, Curr Opin Rheumatol 18 (2006), 108-117.
16. M. Serdaroglu, H. Cakirbay, O. Deger et al., The association of anti-CCP antibodies with disease activity in rheumatoid arthritis, 28 (2008), 965-970.
17. R. Sghiri, E. Bouagina, H. Zaglaoui, H. Mestiri et al., Diagnostic performances of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis, Rheumatol Int 27 (2007), 1125-1130.
18. K. Stankovic and G. Grateau, Auto inflammatory syndromes: Diagnosis and treatment, Joint Bone Spine 74 (2007), 544-550.
19. Y. Takasaki, K. Yamanaka, C. Takasaki et al., Anticyclic citrullinated peptide antibodies in patients with mixed connective tissue disease, Mod Rheumatol 14 (2004), 367-375.
20. M. Tunca, S. Akar, F. Onen et al., (Turkish FMF Study Group). Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study, Medicine (Baltimore) 84 (2005), 1-11.
21. W.J. van Venrooij, A.J. Zendman and G.J. Pruijn, Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis, Autoimmun Rev 6 (2006), 37-41.
22. B. Vander Cruyssen, I.E.A. Hoffman, H. Zmierczak et al., Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis, Ann Rheum Dis 64 (2005), 1145-1149.